Dr. Amy C. Vander Woude, MD

  • Grand Rapids, MI
  • Hematologist and oncologist
NPI1427059781PAC ID1456368471
Medicare services, 2024
6,033
Medicare patients, 2024
368
Part D claims, 2024
2,085
Clinical trials
1
MIPS score, 2024
100
Practice address
100 Michigan St NE, Grand Rapids, MI 49503
Practice phone
Call (616) 391-1774
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

See all 6 affiliations

Find Dr. Vander Woude's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Amy C. Vander Woude is a hematologist and oncologist in Grand Rapids, Michigan

Dr. Vander Woude practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Dr. Vander Woude's NPI, 1427059781, was assigned on August 9, 2005. Dr. Vander Woude graduated from Wake Forest University School of Medicine in 1989. Dr. Vander Woude holds Michigan license 4301054393.

NPI and contact details
Medicare PAC ID
1456368471
NPI enumeration date
August 9, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(616) 391-1774
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
63
Medical school graduation
1989

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Amy C. Vander Woude practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan

Dr. Vander Woude's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Source: Dmand AI Affiliation Data

Dr. Amy C. Vander Woude is affiliated with 5 sites of care and 1 medical group

Dr. Vander Woude's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Dr. Vander Woude is also affiliated with Trinity Health Grand Rapids Hospital. The medical group on file is The Cancer & Hematology Centers. Dmand AI also links Dr. Vander Woude to 3 more hospitals, each named with a free account.

See all 6 affiliations for Dr. Vander Woude

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Amy C. Vander Woude's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vander Woude practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Corewell Health Grand Rapids Hospitals - ButterworthAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Vander Woude practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Corewell Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Amy C. Vander Woude is one of 298 hematologists and oncologists in Michigan

Hematology and oncology is Dr. Vander Woude's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vander Woude is licensed in Michigan.

Specialties and state licenses

  • Hematology and oncology, MichiganPrimaryLicense 4301054393 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Vander Woude

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Amy C. Vander Woude billed Medicare for 6,033 services in 2024

CMS data shows 6,033 Medicare services from Dr. Vander Woude across 41 procedure codes in 2024, for 368 Medicare patients. Medicare paid $154,533 for them.

Medicare services, 20246,033
Medicare patients368
Paid by Medicare$154,533
Procedure codes41

Dr. Vander Woude's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 6,8172024: 2,36865%
Lab and pathology
2023: 1,3192024: 1,3926%
Tests and treatments
2023: 8452024: 97816%
Surgery
2023: 5372024: 59611%
Office and hospital visits
2023: 6482024: 53318%
Other services
2023: 1272024: 16631%

Where Dr. Vander Woude's Medicare services took place, 2024

  • In an office5,93398%
  • In a facility1002%

Dr. Vander Woude compared with the Michigan median for hematologists and oncologists, 2024

  • Dr. Vander Woude
  • Michigan median
Medicare services
6,033vs 6199.7 times
Medicare patients
368vs 22861% above
Part D claims
1,897vs 3785.0 times

Medians across 291 hematologists and oncologists in Michigan with Dmand AI profiles that report each measure.

Dr. Vander Woude's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Vander Woude

Need commercial claims for Dr. Vander Woude?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vander Woude and other hematologists and oncologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Amy C. Vander Woude treated 368 Medicare patients in 2024, average age 72

CMS counts 368 Medicare patients who saw Dr. Vander Woude in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have cancer, and 71% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vander Woude's median patient age at 65, with 90% women.

Medicare patients, 2024368
Average age72
Average risk score1.92
Also on Medicaid11%

Dr. Vander Woude's Medicare patients by age, 2024

Dr. Vander Woude's Medicare patients by sex, 2024

  • Women28678%
  • Men8222%

Chronic conditions among Dr. Vander Woude's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol71%
  3. High blood pressure67%
  4. Arthritis51%
  5. Mood disorders34%
  6. Anxiety31%
  7. Depression30%
  8. Diabetes28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Vander Woude's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women90%
  • Men10%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Amy C. Vander Woude wrote 2,085 Medicare Part D claims in 2024

In 2024, Dr. Vander Woude wrote 2,085 Medicare Part D claims for 489 patients. 80% of them were for generic drugs. CMS names the drug for 1,897 of them, across 29 drugs with 11 or more claims each, at $4,393,539 in total drug cost. In 2023, CMS named 1,614 claims across 23 drugs.

Part D claims, 20242,085
Drugs named by CMS29
Total drug cost$4.4M
Part D patients489

Dr. Vander Woude's Part D claims by kind of drug, 2024

  • Generic1,674 claims80%
  • Brand-name411 claims20%

Dr. Vander Woude's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Vander Woude's Part D claims, 2024

  • Opioids2%40 of 2,085 claims
  • Antibiotics2%35 of 2,085 claims
  • Antipsychotics, patients 65 and over2%32 of 2,085 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6142024: 1,89718%

Drugs named by CMS: 29 in 2024, 23 in 2023.

See all prescribing by Dr. Vander Woude

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Amy C. Vander Woude scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Vander Woude for performance year 2024, reported as part of a group. Dr. Vander Woude accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Vander Woude's MIPS scores, performance year 2024

  • 100of 100Final score
  • 96of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Vander Woude by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Amy C. Vander Woude has worked on 1 clinical trial

Dmand AI links Dr. Vander Woude to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Vander Woude that name 1 trial.

Conditions in Dr. Vander Woude's trials

  • Breast Neoplasms
  • Breast Diseases

Investigators on the most trials with Dr. Vander Woude

Recent clinical trials with Dr. Vander Woude

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Amy C. Vander Woude received $9,549 in industry payments from 2016 to 2025

CMS Open Payments shows 87 general payments to Dr. Vander Woude from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Pfizer Inc. paid the most, $7,174. It also lists 1 research payment totaling $561 in 2021, naming 1 clinical trial.

General payments to Dr. Vander Woude by program year, 2016 to 2025

General payments to Dr. Vander Woude by kind, 2016 to 2025

$9.5Kin total
  • Consulting fees$5,00052%
  • Food and beverage$2,47326%
  • Travel and lodging$2,03221%
  • Education$450%

Companies that paid Dr. Vander Woude the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Vander Woude

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Amy C. Vander Woude graduated from Wake Forest University School of Medicine

Dr. Vander Woude graduated from Wake Forest University School of Medicine in 1989.

  1. Medical schoolWake Forest University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Amy C. Vander Woude's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Amy C. Vander Woude

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Amy C. Vander Woude's NPI number?

Dr. Amy C. Vander Woude's NPI number is 1427059781. It was assigned on August 9, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Amy C. Vander Woude?

Dr. Amy C. Vander Woude is a hematologist and oncologist in Grand Rapids, Michigan. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Amy C. Vander Woude practice?

Dr. Vander Woude practices at 100 Michigan St NE, Grand Rapids, MI 49503. Dr. Vander Woude's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Dmand AI also links Dr. Vander Woude to 3 hospitals.

What is Dr. Amy C. Vander Woude's office phone number?

The practice phone on file for Dr. Vander Woude is (616) 391-1774.

What is Dr. Amy C. Vander Woude's medical license number?

Dr. Vander Woude holds Michigan license 4301054393.

Which hospitals is Dr. Amy C. Vander Woude affiliated with?

Dr. Vander Woude practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan. Dr. Vander Woude is also affiliated with Trinity Health Grand Rapids Hospital. Dmand AI links Dr. Vander Woude to 3 more hospitals.

What medical group is Dr. Amy C. Vander Woude part of?

Dr. Vander Woude is linked to The Cancer & Hematology Centers.

Does Dr. Amy C. Vander Woude accept Medicare?

Yes. CMS data shows Dr. Vander Woude billed Medicare for 6,033 services in 2024, and Dr. Vander Woude accepts Medicare assignment.

What is Dr. Amy C. Vander Woude's MIPS score?

Dr. Vander Woude's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

How many Medicare patients does Dr. Amy C. Vander Woude see?

CMS counts 368 Medicare patients who saw Dr. Vander Woude in 2024, with an average age of 72.

Show 6 more questionsShow fewer questions

What services does Dr. Amy C. Vander Woude bill to Medicare?

In 2024, Dr. Vander Woude's most billed Medicare services were injected or infused drug (J1100), surgery: heart and blood vessels (36415) and lab and pathology test (85025).

Where did Dr. Amy C. Vander Woude go to medical school?

Dr. Vander Woude graduated from Wake Forest University School of Medicine in 1989.

What drugs does Dr. Amy C. Vander Woude prescribe most?

In 2024 Medicare Part D data, Dr. Vander Woude's most prescribed drugs by claims were Anastrozole, Letrozole and Ibrance.

Has Dr. Amy C. Vander Woude received payments from drug or device companies?

CMS Open Payments shows $9,549 in general payments to Dr. Vander Woude from 27 companies from 2016 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Amy C. Vander Woude been practicing?

Dr. Vander Woude graduated from medical school in 1989, 37 years ago.

Does Dr. Amy C. Vander Woude do research?

Dr. Vander Woude has worked on 1 clinical trial.

Selling to hematology and oncology practices?

See hematologists and oncologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)